Novartis takes next step in Russia, halting new trials and enrollment as Big Pharma responds to Ukraine invasion
After Novartis announced it was trimming down some of its business activities in Russia, the global pharma is taking the next step — and this time …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
